A Multicenter Phase II Study of Second‐Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First‐Line Sorafenib Monotherapy
Zhong‐Zhe Lin
◽
Bang‐Bin Chen
◽
Yi‐Ping Hung
◽
Po‐Hsiang Huang
◽
Ying‐Chun Shen
◽
...
2013 ◽
Vol 85
(1)
◽
pp. 44-52
◽
Chih-Hung Hsu
◽
Yoon Koo Kang
◽
Tsai-Shen Yang
◽
Chia-Tung Shun
◽
Yu-Yun Shao
◽
...
2016 ◽
Vol 77
(2)
◽
pp. 243-250
◽
Hiroaki Nagamatsu
◽
Shuji Sumie
◽
Takashi Niizeki
◽
Nobuyoshi Tajiri
◽
Hideki Iwamoto
◽
...
2006 ◽
Vol 42
(4)
◽
pp. 456-459
◽
Valérie Boige
◽
Julien Taïeb
◽
Mohamed Hebbar
◽
David Malka
◽
Thierry Debaere
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4180-4180
V. Boige
◽
J. Taieb
◽
M. Hebbar
◽
E. Magherini
◽
D. Mignard
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4072-4072
◽
P. K. Chow
◽
D. Poon
◽
K. M. Win
◽
H. Singh
◽
H. S. Han
◽
...
2018 ◽
Vol 48
(4)
◽
pp. 317-321
◽
Eiichiro Suzuki
◽
Shuichi Kaneko
◽
Takuji Okusaka
◽
Masafumi Ikeda
◽
Kensei Yamaguchi
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4180-4180
V. Boige
◽
J. Taieb
◽
M. Hebbar
◽
E. Magherini
◽
D. Mignard
◽
...
2017 ◽
Vol 22
(7)
◽
pp. 780
◽
Ghassan K. Abou‐Alfa
◽
Jean‐Frederic Blanc
◽
Steven Miles
◽
Tom Ganten
◽
Jörg Trojan
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. 4083-4083
◽
A. X. Zhu
◽
R. S. Finn
◽
M. F. Mulcahy
◽
J. S. Gurtler
◽
W. Sun
◽
...
2017 ◽
Vol 7
(2)
◽
pp. 148-164
◽
Masatoshi Kudo
◽
Yoon-Koo Kang
◽
Joong-Won Park
◽
Shukui Qin
◽
Yoshitaka Inaba
◽
...